Compare ANIP & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | YELP |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1999 | 2011 |
| Metric | ANIP | YELP |
|---|---|---|
| Price | $78.53 | $27.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | ★ $110.00 | $29.17 |
| AVG Volume (30 Days) | 294.9K | ★ 889.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 419.23 | 19.15 |
| EPS | ★ 3.32 | 2.24 |
| Revenue | $206,547,000.00 | ★ $1,464,955,000.00 |
| Revenue This Year | $21.01 | $2.19 |
| Revenue Next Year | $17.59 | $2.34 |
| P/E Ratio | $23.94 | ★ $13.01 |
| Revenue Growth | 2.47 | ★ 3.75 |
| 52 Week Low | $56.71 | $19.60 |
| 52 Week High | $99.50 | $40.25 |
| Indicator | ANIP | YELP |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 59.57 |
| Support Level | $78.80 | $27.29 |
| Resistance Level | $83.58 | $30.75 |
| Average True Range (ATR) | 2.41 | 0.84 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 46.30 | 61.53 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.